vialaudit

affiliate disclosure · We earn affiliate commission on some vendor links. Audits, scores, and rankings are independent — vendors do not pay for placement and do not see drafts. read more →

peptide guide · healing & repair · trending 68

TB-500

Thymosin Beta-4 fragment

Synthetic fragment of the naturally occurring thymosin beta-4. Researched for cell migration and tissue repair.

category
healing & repair
research dosing
Research literature cites 2–5 mg twice weekly for 4–6 weeks.
vendors stocking
1
§ 01

Research notes

Mechanism

TB-500 is a synthetic peptide based on a fragment of thymosin beta-4, a naturally occurring 43-amino-acid protein involved in actin regulation, cell migration, and tissue repair. Preclinical research focuses on its role in cell migration to injury sites and angiogenesis.

Research dosing

Twice-weekly injection at 2–5 mg per dose is the most commonly cited research protocol. Loading-phase variants front-load higher doses for the first 4–6 weeks.

Audit focus

For TB-500, the variance between vendors is mostly on identity confirmation rather than purity. We've seen multiple grey-market batches that were under-strength rather than off-spec; mass-spec identity tests catch these.

§ 02

What it's researched for

  • recovery
  • tissue repair
§ 03

Where to source it

top 3 by compositeSee all 1 vendors
vendor · ships us

Particle Peptides

public-data

Best price-to-purity ratio in the market right now.

88/100
PARTICLE10
10% off, stackable with bulk
copy
4d ship · last test 2026-04-08T00:00:00.000ZRead audit →
§ 04

Sources

  1. [01]Thymosin beta 4 and its actin-binding partners
read next

Other peptides

peptide guideBPC-157Synthetic peptide derived from a protein fragment in gastric juice. Mechanism not fully…Body Protection Compound 157
the roundup · monthly

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 subscribers· 0 sponsored items· 11 issues since launch